Using an in vitro BBB model, composed of endothelial cells and astrocytes, we demonstrated that Kv1.3 inhibition reduced glioma-induced BBB disruption, and increased the expression of tight junction proteins on endothelial cells. Here, KCNA3 is linked to central nervous system cancer.